Arthneeti
Sale is live|00:00:00
RHI Magnesita India LtdQ3 FY25

RHI Magnesita India Ltd Q3 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 376P/E: 46.8Market Cap: ₹8.0K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

No

0 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Targeting 80%-85% capacity utilization in the next 2 years without major new plant expansions; only minor additions to specific product lines planned.
  • Expecting gradual demand growth post-monsoon in steel and cement sectors, with market share gains in flow control segment since July.
  • Dalmia plant volume grew 26% quarter-on-quarter, with margins improving from 8.7% to 11.4%; further growth expected with product transfers to this plant in next 6 months.
  • Flow control, about 28% of revenue, shows margin stability (21%-23%) and market share gains (8%-10% expected in second half FY ’26).
  • Export contribution stable around 10% of total revenue, with plans for gradual growth through semi-commercial trials internationally.
  • New green product lines (eco-grade bricks) in early trial stage; material contribution expected only in next 2-3 years.
  • Overall revenue growth driven by better product mix, market share gains, and operational efficiencies.

Margin guidance

Category 3
  • The company aims to achieve 80-85% capacity utilization in the next 2 years without major new plant expansions, focusing on add-on equipment upgrades.
  • EBITDA margin for FY '26 is expected to be around 13-14%, similar to FY '25, driven by raw material cost decreases, product optimization, and productivity improvements.
  • Revenue growth is anticipated via market share gains, better product mix (high-margin industrial orders), and expanding flow control business (28-30% revenue contribution).
  • The Dalmia acquisition is expected to improve profitability over 2-3 years, with tax credit benefits post 5 years.
  • The company targets steady margin improvement from price hikes in flow control contracts and cost benefits via localization of tech (e.g., UREX, green bricks).
  • Capex spend supports efficiency gains and increased productivity; INR 150 crores planned for FY '26 with INR 90-100 crores expected next year.
  • Overall outlook is gradual earnings growth aligned with industrial demand and operational improvements.

3 more insights locked — sign up free to unlock

Fundraise plans

  • There is no explicit mention of any current or planned fundraising through new debt or equity in the provided excerpts.
  • The company is focusing on internal capacity utilization improvement (aiming for 80%-85% in 2 years) rather than major capacity expansions.
  • Capital expenditure (capex) plans include around INR 150 crores budgeted for the current year, with INR 60 crores spent in H1 and the rest planned for H2; next year's capex is expected around INR 90-100 crores.
  • Capex is focused on refurbishment and efficiency improvements (e.g., SACMI press with a 14-month lead time).
  • There is no mention of new fundraising linked to these capex plans; spending appears to be funded from existing resources.
  • Financing cost improvements are expected from FX gains, but no new borrowing plans are disclosed.

Order book

  • There is mention of industrial orders, which are naturally higher margin percentage orders, expected to come in the upcoming quarters.
  • The company expects better product mix and performance bonuses linked to gained market share, particularly in ladle business.
  • The flow control business, contributing around 28% of revenue, is expected to see a substantial uptick next year, with about 5%-6% increase in revenue contribution for standalone.
  • Market share gains in Flow Control from July onwards are noted, with 8%-10% market share gain anticipated in the second half of the year.
  • No specific numeric value of current or expected order book/pending orders is provided.
  • The company focuses on long-term relationships, a diverse portfolio, and end-to-end solutions, suggesting ongoing order flow aligned with strategic growth.

Capex plans

No
  • Capex budget for current year is INR 150 crores; INR 60 crores spent in H1, balance expected in H2; some spillover to next year.
  • Next year's capex expected around INR 90-100 crores.
  • Focus is on refurbishments and adding press, mixers, dryers, kilns rather than new plant expansions.
  • New machines (e.g., SACMI press with 14 months lead time) will improve productivity, reduce labor cost, and rejection levels.
  • Investments have strict ROIC criteria: minimum 3-year payback, double-digit returns aimed.
  • No major capacity expansion planned; target capacity utilization of 80-85% in next 2 years.
  • Strategic technology transfers (e.g., for high-margin products like UREX, Resistal, eco-grade bricks) planned to improve margins and working capital efficiency.
  • No plans to bulk up alumina/raw material inventory currently; capital deployed judiciously given supply and price outlook.

How does RHI Magnesita India Ltd rank vs peers in Industrial Products?

Pro feature
1RHI Magnesita India Ltd
Rev 3Mar 3

See full Industrial Products sector rankings

Want more stocks like RHI Magnesita India Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio